Cargando…
Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476917/ http://dx.doi.org/10.2337/dc12-1124 |
| _version_ | 1782247131963195392 |
|---|---|
| author | Fraser, David A. Diep, Lien M. Hovden, Inger Anette Nilsen, Kristian B. Sveen, Kari Anne Seljeflot, Ingebjørg Hanssen, Kristian F. |
| author_facet | Fraser, David A. Diep, Lien M. Hovden, Inger Anette Nilsen, Kristian B. Sveen, Kari Anne Seljeflot, Ingebjørg Hanssen, Kristian F. |
| author_sort | Fraser, David A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3476917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34769172013-11-01 Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 Fraser, David A. Diep, Lien M. Hovden, Inger Anette Nilsen, Kristian B. Sveen, Kari Anne Seljeflot, Ingebjørg Hanssen, Kristian F. Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2012-11 2012-10-13 /pmc/articles/PMC3476917/ http://dx.doi.org/10.2337/dc12-1124 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Comments and Responses Fraser, David A. Diep, Lien M. Hovden, Inger Anette Nilsen, Kristian B. Sveen, Kari Anne Seljeflot, Ingebjørg Hanssen, Kristian F. Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 |
| title | Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 |
| title_full | Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 |
| title_fullStr | Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 |
| title_full_unstemmed | Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 |
| title_short | Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 |
| title_sort | response to comment on: fraser et al. the effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. diabetes care 2012;35:1095–1097 |
| topic | Online Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476917/ http://dx.doi.org/10.2337/dc12-1124 |
| work_keys_str_mv | AT fraserdavida responsetocommentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097 AT dieplienm responsetocommentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097 AT hovdeningeranette responsetocommentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097 AT nilsenkristianb responsetocommentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097 AT sveenkarianne responsetocommentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097 AT seljeflotingebjørg responsetocommentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097 AT hanssenkristianf responsetocommentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097 |